Home Stocks ACET Adicet Bio Inc (NASDAQ: ACET) Healthcare · Biotechnology
$2.50 −0.28 (−10.07%)
Last close · Nov 18, 2026 · NASDAQ USD
The Quantellect read. ACET fell 10.07% in the Nov 18 session to $2.50, which is 75.9% below its 52-week high of $10.37. Short interest is 7.36% of float with a 0.57% borrow fee. Five active firms cover the stock as of Nov 18, 2026; five active firms with targets average $37.80 over 12 months. Descriptive summary of the data on this page, not a recommendation.
Relative valuation Lower multiples than peers P/S 9.7× vs peer median 13.9×
Momentum Oversold RSI (14) 18.5 (overbought above 70, oversold below 30) · as of Nov 17, 2026
Trend Below both averages $2.78 vs $5.66 and $7.37 · as of Nov 17, 2026
Short interest 7.4% of float FINRA settlement Oct 30, 2026
SMA 10 $2.93 SMA 20 $3.35 SMA 50 $5.66 SMA 200 $7.37
Nov 17, 2026 O $2.72 H $2.84 L $2.60 C $2.78 Vol 390K
×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date May 18, 2026 ET Last date Nov 17, 2026 ET Open $7.60 High $9.97 Low $2.60 Close $2.78 Volume 21,714,276 Plotted bars 128
Plotted OHLCV bars May 18, 2026 ET · Open $7.60 · High $7.76 · Low $7.32 · Close $7.50 · Volume 100,901 May 19, 2026 ET · Open $7.50 · High $7.50 · Low $7.09 · Close $7.25 · Volume 171,473 May 20, 2026 ET · Open $7.25 · High $7.91 · Low $7.23 · Close $7.76 · Volume 154,128 May 21, 2026 ET · Open $7.71 · High $8.03 · Low $7.47 · Close $7.89 · Volume 105,783 May 22, 2026 ET · Open $7.90 · High $8.35 · Low $7.90 · Close $8.30 · Volume 92,027 May 26, 2026 ET · Open $8.44 · High $8.62 · Low $8.03 · Close $8.33 · Volume 90,235 May 27, 2026 ET · Open $8.36 · High $8.68 · Low $8.18 · Close $8.50 · Volume 100,692 May 28, 2026 ET · Open $8.38 · High $8.74 · Low $8.29 · Close $8.64 · Volume 114,373 May 29, 2026 ET · Open $8.64 · High $9.47 · Low $8.52 · Close $9.31 · Volume 203,842 Jun 1, 2026 ET · Open $9.32 · High $9.32 · Low $8.74 · Close $8.78 · Volume 66,790 Jun 2, 2026 ET · Open $8.66 · High $8.67 · Low $8.11 · Close $8.11 · Volume 170,763 Jun 3, 2026 ET · Open $8.06 · High $8.29 · Low $7.64 · Close $7.83 · Volume 113,720 Jun 4, 2026 ET · Open $7.89 · High $8.34 · Low $7.86 · Close $8.15 · Volume 63,316 Jun 5, 2026 ET · Open $8.05 · High $8.06 · Low $7.26 · Close $7.26 · Volume 86,581 Jun 8, 2026 ET · Open $7.46 · High $7.46 · Low $7.13 · Close $7.22 · Volume 53,876 Jun 9, 2026 ET · Open $7.35 · High $7.55 · Low $7.02 · Close $7.31 · Volume 54,641 Jun 10, 2026 ET · Open $7.27 · High $7.42 · Low $7.24 · Close $7.31 · Volume 34,919 Jun 11, 2026 ET · Open $7.39 · High $7.74 · Low $7.31 · Close $7.55 · Volume 42,075 Jun 12, 2026 ET · Open $7.63 · High $8.33 · Low $7.44 · Close $8.05 · Volume 121,739 Jun 15, 2026 ET · Open $8.12 · High $8.37 · Low $8.11 · Close $8.11 · Volume 32,008 Jun 16, 2026 ET · Open $8.12 · High $8.13 · Low $7.72 · Close $7.76 · Volume 77,747 Jun 17, 2026 ET · Open $7.86 · High $8.33 · Low $7.79 · Close $8.10 · Volume 244,198 Jun 18, 2026 ET · Open $8.02 · High $8.15 · Low $8.02 · Close $8.10 · Volume 36,382 Jun 22, 2026 ET · Open $8.08 · High $8.40 · Low $8.08 · Close $8.23 · Volume 64,370 Jun 23, 2026 ET · Open $8.07 · High $8.44 · Low $8.07 · Close $8.15 · Volume 32,079 Jun 24, 2026 ET · Open $8.21 · High $8.43 · Low $8.12 · Close $8.25 · Volume 84,539 Jun 25, 2026 ET · Open $8.25 · High $8.30 · Low $7.88 · Close $7.90 · Volume 88,626 Jun 26, 2026 ET · Open $7.86 · High $8.37 · Low $7.86 · Close $8.37 · Volume 95,749 Jun 29, 2026 ET · Open $8.38 · High $8.62 · Low $8.34 · Close $8.56 · Volume 74,352 Jun 30, 2026 ET · Open $8.58 · High $8.81 · Low $8.47 · Close $8.64 · Volume 171,798 Jul 1, 2026 ET · Open $8.58 · High $9.02 · Low $8.40 · Close $8.62 · Volume 90,120 Jul 2, 2026 ET · Open $8.73 · High $9.39 · Low $8.70 · Close $9.00 · Volume 101,107 Jul 6, 2026 ET · Open $9.10 · High $9.42 · Low $9.06 · Close $9.07 · Volume 64,602 Jul 7, 2026 ET · Open $9.13 · High $9.13 · Low $8.49 · Close $8.60 · Volume 66,249 Jul 8, 2026 ET · Open $8.53 · High $9.31 · Low $8.53 · Close $9.25 · Volume 136,380 Jul 9, 2026 ET · Open $9.25 · High $9.32 · Low $8.88 · Close $8.94 · Volume 98,315 Jul 10, 2026 ET · Open $8.95 · High $8.98 · Low $8.68 · Close $8.83 · Volume 60,801 Jul 13, 2026 ET · Open $8.79 · High $9.15 · Low $8.55 · Close $8.55 · Volume 116,361 Jul 14, 2026 ET · Open $8.64 · High $9.08 · Low $8.51 · Close $8.83 · Volume 119,827 Jul 15, 2026 ET · Open $8.79 · High $8.88 · Low $8.44 · Close $8.68 · Volume 53,951 Jul 16, 2026 ET · Open $8.60 · High $8.67 · Low $7.94 · Close $8.22 · Volume 113,892 Jul 17, 2026 ET · Open $8.16 · High $8.27 · Low $7.95 · Close $8.12 · Volume 104,891 Jul 20, 2026 ET · Open $7.96 · High $8.13 · Low $7.76 · Close $7.89 · Volume 74,921 Jul 21, 2026 ET · Open $7.96 · High $8.31 · Low $7.91 · Close $8.12 · Volume 43,295 Jul 22, 2026 ET · Open $8.07 · High $8.63 · Low $8.00 · Close $8.57 · Volume 95,174 Jul 23, 2026 ET · Open $8.35 · High $8.56 · Low $8.14 · Close $8.42 · Volume 177,679 Jul 24, 2026 ET · Open $8.39 · High $8.39 · Low $7.75 · Close $7.79 · Volume 71,206 Jul 27, 2026 ET · Open $7.84 · High $8.26 · Low $7.74 · Close $8.06 · Volume 107,923 Jul 28, 2026 ET · Open $8.10 · High $8.46 · Low $7.78 · Close $8.20 · Volume 54,880 Jul 29, 2026 ET · Open $8.28 · High $8.43 · Low $8.09 · Close $8.30 · Volume 92,146 Jul 30, 2026 ET · Open $8.38 · High $9.11 · Low $8.33 · Close $9.06 · Volume 60,754 Jul 31, 2026 ET · Open $8.97 · High $9.21 · Low $8.55 · Close $9.11 · Volume 123,468 Aug 3, 2026 ET · Open $9.08 · High $9.84 · Low $9.00 · Close $9.24 · Volume 135,437 Aug 4, 2026 ET · Open $9.35 · High $9.47 · Low $9.19 · Close $9.21 · Volume 95,400 Aug 5, 2026 ET · Open $9.31 · High $9.50 · Low $9.01 · Close $9.16 · Volume 43,379 Aug 6, 2026 ET · Open $8.71 · High $8.88 · Low $7.42 · Close $7.93 · Volume 179,951 Aug 7, 2026 ET · Open $8.12 · High $8.30 · Low $7.98 · Close $7.98 · Volume 80,453 Aug 10, 2026 ET · Open $7.96 · High $8.23 · Low $7.85 · Close $8.11 · Volume 85,811 Aug 11, 2026 ET · Open $8.15 · High $8.29 · Low $7.93 · Close $8.23 · Volume 65,757 Aug 12, 2026 ET · Open $8.30 · High $8.35 · Low $8.18 · Close $8.26 · Volume 39,850 Aug 13, 2026 ET · Open $8.35 · High $8.50 · Low $8.25 · Close $8.26 · Volume 51,263 Aug 14, 2026 ET · Open $8.30 · High $8.38 · Low $8.15 · Close $8.38 · Volume 57,935 Aug 17, 2026 ET · Open $8.46 · High $8.99 · Low $8.46 · Close $8.74 · Volume 93,225 Aug 18, 2026 ET · Open $8.75 · High $9.22 · Low $8.70 · Close $9.11 · Volume 101,413 Aug 19, 2026 ET · Open $8.99 · High $9.60 · Low $8.99 · Close $9.49 · Volume 84,849 Aug 20, 2026 ET · Open $9.62 · High $9.65 · Low $9.08 · Close $9.38 · Volume 65,528 Aug 21, 2026 ET · Open $9.42 · High $9.63 · Low $9.10 · Close $9.19 · Volume 80,499 Aug 24, 2026 ET · Open $9.21 · High $9.21 · Low $8.74 · Close $8.90 · Volume 64,334 Aug 25, 2026 ET · Open $8.98 · High $9.15 · Low $8.78 · Close $9.00 · Volume 69,875 Aug 26, 2026 ET · Open $8.98 · High $9.04 · Low $8.63 · Close $8.95 · Volume 119,339 Aug 27, 2026 ET · Open $9.00 · High $9.18 · Low $8.84 · Close $9.01 · Volume 261,593 Aug 28, 2026 ET · Open $9.22 · High $9.25 · Low $8.76 · Close $9.06 · Volume 111,654 Aug 31, 2026 ET · Open $8.92 · High $9.07 · Low $8.62 · Close $8.70 · Volume 112,000 Sep 1, 2026 ET · Open $8.87 · High $9.45 · Low $8.77 · Close $9.26 · Volume 134,126 Sep 2, 2026 ET · Open $9.35 · High $9.65 · Low $9.00 · Close $9.26 · Volume 60,954 Sep 3, 2026 ET · Open $9.26 · High $9.64 · Low $9.05 · Close $9.43 · Volume 78,756 Sep 4, 2026 ET · Open $9.33 · High $9.76 · Low $9.26 · Close $9.59 · Volume 44,608 Sep 8, 2026 ET · Open $9.61 · High $9.97 · Low $9.38 · Close $9.73 · Volume 81,847 Sep 9, 2026 ET · Open $9.67 · High $9.95 · Low $9.44 · Close $9.54 · Volume 93,333 Sep 10, 2026 ET · Open $9.46 · High $9.68 · Low $9.31 · Close $9.53 · Volume 118,997 Sep 11, 2026 ET · Open $9.65 · High $9.80 · Low $9.38 · Close $9.52 · Volume 119,504 Sep 14, 2026 ET · Open $9.51 · High $9.84 · Low $9.42 · Close $9.70 · Volume 124,757 Sep 15, 2026 ET · Open $9.70 · High $9.70 · Low $7.91 · Close $8.51 · Volume 479,242 Sep 16, 2026 ET · Open $8.52 · High $9.44 · Low $8.45 · Close $9.05 · Volume 258,210 Sep 17, 2026 ET · Open $9.20 · High $9.33 · Low $8.86 · Close $9.01 · Volume 130,675 Sep 18, 2026 ET · Open $8.96 · High $9.41 · Low $8.76 · Close $9.18 · Volume 114,529 Sep 21, 2026 ET · Open $9.23 · High $9.24 · Low $8.78 · Close $8.93 · Volume 49,788 Sep 22, 2026 ET · Open $9.00 · High $9.44 · Low $8.98 · Close $9.15 · Volume 87,830 Sep 23, 2026 ET · Open $9.12 · High $9.31 · Low $8.42 · Close $8.49 · Volume 263,245 Sep 24, 2026 ET · Open $8.49 · High $8.49 · Low $7.89 · Close $8.27 · Volume 358,549 Sep 25, 2026 ET · Open $8.29 · High $9.11 · Low $8.29 · Close $9.02 · Volume 638,601 Sep 28, 2026 ET · Open $7.96 · High $7.96 · Low $6.25 · Close $6.35 · Volume 2,148,970 Sep 29, 2026 ET · Open $6.41 · High $7.06 · Low $6.37 · Close $6.83 · Volume 668,201 Sep 30, 2026 ET · Open $6.80 · High $7.28 · Low $6.71 · Close $7.14 · Volume 211,064 Oct 1, 2026 ET · Open $7.06 · High $7.17 · Low $6.64 · Close $6.64 · Volume 149,042 Oct 2, 2026 ET · Open $6.70 · High $6.82 · Low $6.50 · Close $6.50 · Volume 164,978 Oct 5, 2026 ET · Open $6.53 · High $6.69 · Low $6.28 · Close $6.47 · Volume 152,772 Oct 6, 2026 ET · Open $6.52 · High $6.55 · Low $6.21 · Close $6.25 · Volume 135,721 Oct 7, 2026 ET · Open $6.21 · High $6.44 · Low $6.12 · Close $6.18 · Volume 214,301 Oct 8, 2026 ET · Open $6.16 · High $6.17 · Low $5.55 · Close $5.74 · Volume 487,862 Oct 9, 2026 ET · Open $5.72 · High $6.05 · Low $5.61 · Close $5.61 · Volume 189,826 Oct 12, 2026 ET · Open $5.55 · High $5.84 · Low $5.17 · Close $5.53 · Volume 145,879 Oct 13, 2026 ET · Open $5.53 · High $5.53 · Low $5.10 · Close $5.11 · Volume 326,904 Oct 14, 2026 ET · Open $5.10 · High $5.27 · Low $4.80 · Close $4.89 · Volume 357,870 Oct 15, 2026 ET · Open $4.90 · High $5.17 · Low $4.88 · Close $5.14 · Volume 155,102 Oct 16, 2026 ET · Open $5.14 · High $5.14 · Low $4.57 · Close $4.57 · Volume 188,794 Oct 19, 2026 ET · Open $4.57 · High $4.75 · Low $4.39 · Close $4.53 · Volume 230,320 Oct 20, 2026 ET · Open $4.53 · High $4.72 · Low $4.49 · Close $4.52 · Volume 126,528 Oct 21, 2026 ET · Open $4.52 · High $4.74 · Low $4.44 · Close $4.49 · Volume 182,002 Oct 22, 2026 ET · Open $4.50 · High $4.72 · Low $4.21 · Close $4.28 · Volume 157,156 Oct 23, 2026 ET · Open $4.22 · High $4.29 · Low $3.96 · Close $3.99 · Volume 162,967 Oct 26, 2026 ET · Open $4.00 · High $4.06 · Low $3.81 · Close $3.94 · Volume 162,814 Oct 27, 2026 ET · Open $3.94 · High $3.97 · Low $3.77 · Close $3.81 · Volume 178,167 Oct 28, 2026 ET · Open $3.80 · High $3.86 · Low $3.71 · Close $3.81 · Volume 178,818 Oct 29, 2026 ET · Open $3.83 · High $3.86 · Low $3.56 · Close $3.58 · Volume 176,209 Oct 30, 2026 ET · Open $3.68 · High $3.74 · Low $3.32 · Close $3.42 · Volume 242,489 Nov 2, 2026 ET · Open $3.42 · High $3.47 · Low $3.18 · Close $3.20 · Volume 250,305 Nov 3, 2026 ET · Open $3.20 · High $3.34 · Low $3.13 · Close $3.17 · Volume 175,833 Nov 4, 2026 ET · Open $3.26 · High $3.31 · Low $2.99 · Close $3.10 · Volume 292,346 Nov 5, 2026 ET · Open $3.03 · High $3.05 · Low $2.87 · Close $2.92 · Volume 420,438 Nov 6, 2026 ET · Open $2.89 · High $3.14 · Low $2.89 · Close $3.05 · Volume 254,061 Nov 9, 2026 ET · Open $3.11 · High $3.20 · Low $2.93 · Close $2.99 · Volume 175,782 Nov 10, 2026 ET · Open $3.00 · High $3.08 · Low $2.86 · Close $3.00 · Volume 382,733 Nov 11, 2026 ET · Open $3.02 · High $3.18 · Low $2.93 · Close $2.99 · Volume 416,466 Nov 12, 2026 ET · Open $2.96 · High $3.08 · Low $2.84 · Close $2.93 · Volume 371,408 Nov 13, 2026 ET · Open $2.92 · High $2.98 · Low $2.73 · Close $2.78 · Volume 286,428 Nov 16, 2026 ET · Open $2.80 · High $2.88 · Low $2.60 · Close $2.75 · Volume 595,400 Nov 17, 2026 ET · Open $2.72 · High $2.84 · Low $2.60 · Close $2.78 · Volume 389,560 Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of Nov 17, 2026, 8:49 PM ET
Initial 6M price range summary Range 6M First close $7.50 Last close $2.78 High $9.97 Low $2.60 Volume 21,714,276
Open $2.75 Nov 18, 2026 session
Previous close $2.78 Nov 17, 2026 close
Day range $2.41 – $2.78 Nov 18, 2026 session
52-week range $2.50 – $10.37 Through Nov 18, 2026
Volume 832.76K Nov 18, 2026 session
Average volume (30 calendar days, 22 sessions) 264.01K Through Nov 18, 2026
Market cap $26.03M
P/E (TTM) negative earnings —
Forward P/E —
EPS (TTM) eps split basis unknown —
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) 1.78
Price history ACET · nasdaq · USD
Last completed session: Nov 17, 2026
Split-adjusted · volume in shares
Missing session: Nov 18, 2026
November 2026 · 12 completed sessions Date Open High Low Close Change Volume Nov 17 2.72 2.84 2.6004 2.78 +0.03+1.090909% 389,560 Open 2.72 High 2.84 Low 2.6004 Nov 16 2.80 2.88 2.60 2.75 −0.03−1.079137% 595,400 Open 2.80 High 2.88 Low 2.60 Nov 13 2.92 2.975 2.73 2.78 −0.15−5.119454% 286,428 Open 2.92 High 2.975 Low 2.73 Nov 12 2.96 3.079 2.84 2.93 −0.06−2.006689% 371,408 Open 2.96 High 3.079 Low 2.84 Nov 11 3.02 3.18 2.93 2.99 −0.01−0.333333% 416,466 Open 3.02 High 3.18 Low 2.93 Nov 10 3.00 3.08 2.86 3.00 +0.01+0.334448% 382,733 Open 3.00 High 3.08 Low 2.86 Nov 9 3.11 3.20 2.925 2.99 −0.06−1.967213% 175,782 Open 3.11 High 3.20 Low 2.925 Nov 6 2.89 3.1442 2.89 3.05 +0.13+4.452055% 254,061 Open 2.89 High 3.1442 Low 2.89 Nov 5 3.03 3.05 2.87 2.92 −0.18−5.806452% 420,438 Open 3.03 High 3.05 Low 2.87 Nov 4 3.26 3.31 2.99 3.10 −0.07−2.208202% 292,346 Open 3.26 High 3.31 Low 2.99 Nov 3 3.20 3.34 3.13 3.17 −0.03−0.9375% 175,833 Open 3.20 High 3.34 Low 3.13 Nov 2 3.42 3.465 3.18 3.20 −0.22−6.432749% 250,305 Open 3.42 High 3.465 Low 3.18
Notable price movement Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.
Oct 16
$4.57 −11.09%
Trading volume was 0.6 times the 30-day average, with 188.79K shares traded.
Sep 28
$6.35 −29.60%
Trading volume was 12.2 times the 30-day average, with 2.15M shares traded.
Sep 25
$9.02 +9.07%
Trading volume was 4.2 times the 30-day average, with 638.6K shares traded.
Options flow — · Options flow not available
Q Score 20 /100 Poor
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Liquidity 27 Short 80 Squeeze 35 Trend 8 Momentum 7 Valuation 65 Stability 23 What each one means Liquidity 27
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short 80
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze 35
Higher scores reflect a higher published Squeeze score within equity peers.
Trend 8
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum 7
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation 65
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability 23
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → How ACET compares with its industry Against 592 other US-listed Biotechnology stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Points of cautionLatest-quarter year-over-year sales growth was -100%, with only 0% of 592 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026 Three-month return was -70.7%, with only 8% of 559 peers reporting a lower value.Peer median −31.6% · As of Nov 16, 2026 Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026 Valuation Lower multiples than peers
Metric ACET Peer median
Profitability Profitability metrics are lower than most peers.
Metric ACET Peer median
Growth Growth metrics are lower than most peers.
Metric ACET Peer median
Quarterly sales growth, year over year −100.0% 0.0%
Lowest of 592 peers Higher than 0% of 592 peers
5-year sales growth rate — 11.3%
Not ranked: only 140 of 592 peers report it
Balance sheet Balance sheet metrics are higher than most peers.
Metric ACET Peer median
Momentum Returns are lower than most peers.
Metric ACET Peer median
1-year return −73.8% −29.3%
Higher than 18% of 522 peers
6-month return −61.7% −24.0%
Higher than 17% of 547 peers
3-month return −70.7% −31.6%
Bottom 10% of peers Higher than 8% of 559 peers
How to read this The dot marks where ACET ranks among its peers on each metric, from lowest (left) to highest (right). The tick in the middle marks the peer median.
Green marks a rank in the top 10% of peers, amber the bottom 10%. Valuation and balance-sheet metrics stay neutral because a high rank there is not better or worse.
A metric is ranked only when enough peers report it. Peers exclude this company. Percentages count peers with a strictly lower value; equal values do not count.
Lowest Median Highest
Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 12, 2026
Upcoming events — · Upcoming events not available
Analyst consensus Buy
0 Strong Buy
5 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 5 active firms as of Nov 18, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $18.00
Average $37.80
High $90.00
As of Nov 18, 2026 across 5 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast → Earnings history — · Earnings history not available
Smart-money activity In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.
Date Type Who Action Amount Source
Feb 20, 2026 Insider buy RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / Kolchinsky Peter / Shah Rajeev M. Buy $543.4K Form 4 Feb 19, 2026 Insider buy RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / Kolchinsky Peter / Shah Rajeev M. Buy $535.5K Form 4 Feb 18, 2026 Insider buy RA CAPITAL MANAGEMENT, L.P. / RA Capital Healthcare Fund LP / Kolchinsky Peter / Shah Rajeev M. Buy $525.0K Form 4 Apr 8, 2026 Insider sell ORBIMED ADVISORS LLC / OrbiMed Capital GP V LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC / OrbiMed Advisors Israel II Ltd / OrbiMed Israel GP II, L.P. / OrbiMed Israel GP Ltd. / OrbiMed Israel BioFund GP Limited Partnership Sell $263.5K Form 4 Apr 8, 2026 Insider sell ORBIMED ADVISORS LLC / OrbiMed Capital GP V LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC / OrbiMed Advisors Israel II Ltd / OrbiMed Israel GP II, L.P. / OrbiMed Israel GP Ltd. / OrbiMed Israel BioFund GP Limited Partnership Sell $204.6K Form 4 Apr 7, 2026 Insider sell ORBIMED ADVISORS LLC / OrbiMed Capital GP V LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC / OrbiMed Advisors Israel II Ltd / OrbiMed Israel GP II, L.P. / OrbiMed Israel GP Ltd. / OrbiMed Israel BioFund GP Limited Partnership Sell $15.3K Form 4 Apr 7, 2026 Insider sell ORBIMED ADVISORS LLC / OrbiMed Capital GP V LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC / OrbiMed Advisors Israel II Ltd / OrbiMed Israel GP II, L.P. / OrbiMed Israel GP Ltd. / OrbiMed Israel BioFund GP Limited Partnership Sell $191.5K Form 4 Oct 8, 2025 Insider buy ORBIMED ADVISORS LLC / OrbiMed Capital GP V LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC / OrbiMed Advisors Israel II Ltd / OrbiMed Israel GP II, L.P. / OrbiMed Israel GP Ltd. / OrbiMed Israel BioFund GP Limited Partnership Buy $3.5M Form 4 Oct 8, 2025 Insider buy ORBIMED ADVISORS LLC / OrbiMed Capital GP V LLC / OrbiMed Capital GP VI LLC / OrbiMed Genesis GP LLC / OrbiMed Advisors Israel II Ltd / OrbiMed Israel GP II, L.P. / OrbiMed Israel GP Ltd. / OrbiMed Israel BioFund GP Limited Partnership Buy $1.5M Form 4 Jun 5, 2024 Insider sell Kauffman Michael Sell $8.4K Form 4 All smart-money activity →
News and press releases Year All 2026 2025 Nov 5, 2026, 4:10 PM ET Oct 30, 2026, 5:38 PM ET Oct 22, 2026, 4:00 PM ET Oct 7, 2025, 6:45 AM ET All ACET news → Company profile Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane
CEO Mr. Chen Schor BA, C.P.A., M.B.A.
Headquarters Boston, MA, United States
Employees 102
IPO date Jan 26, 2018
Sector Healthcare
Industry Biotechnology Q Score 20 /100 Poor
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Liquidity 27 Short 80 Squeeze 35 Trend 8 Momentum 7 Valuation 65 Stability 23 What each one means Liquidity 27
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short 80
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze 35
Higher scores reflect a higher published Squeeze score within equity peers.
Trend 8
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum 7
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation 65
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability 23
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → Upcoming events — · Upcoming events not available
Analyst consensus Buy
0 Strong Buy
5 Buy
0 Neutral
0 Sell
0 Strong Sell
Based on 5 active firms as of Nov 18, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $18.00
Average $37.80
High $90.00
As of Nov 18, 2026 across 5 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast → Earnings history — · Earnings history not available
Company profile Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane
CEO Mr. Chen Schor BA, C.P.A., M.B.A.
Headquarters Boston, MA, United States
Employees 102
IPO date Jan 26, 2018
Sector Healthcare
Industry Biotechnology